Clinical Study

Second Generation FIT® is also the test of choice for large clinical trials.  When the drug Casperome® was in clinical trials to manage patients with ulcerative colitis in remission, doctors depended on Second Generation FIT® to provide the vital information regarding remission status they needed using the fecal immunochemical test.